Your browser doesn't support javascript.
Hydroxychloroquine, COVID-19 and diabetes. Why it is a different story.
Stoian, Anca Pantea; Catrinoiu, Doina; Rizzo, Manfredi; Ceriello, Antonio.
  • Stoian AP; Diabetes, Nutrition and Metabolic Diseases Department, "Carol Davila" University of Medicine, Bucharest, Romania.
  • Catrinoiu D; Faculty of Medicine, Clinical Center of Diabetes, Nutrition and Metabolic Diseases, Ovidius University of Constanta, Constanta, Romania.
  • Rizzo M; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, South Carolina, USA.
  • Ceriello A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Diabetes Metab Res Rev ; 37(2): e3379, 2021 02.
Article in English | MEDLINE | ID: covidwho-615188
ABSTRACT
Hydroxychloroquine has been proposed for the cure of the COVID-19 due to its anti-inflammatory and anti-viral action. People with diabetes are more prone to severe outcome if affected by COVID-19 and the use of Hydroxychloroquine might have some benefit in this setting. However, the use of Hydroxychloroquine in diabetes deserves particular attention for its documented hypoglycemic action.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Glucose / Diabetes Mellitus / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Diabetes Metab Res Rev Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article Affiliation country: Dmrr.3379

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Glucose / Diabetes Mellitus / COVID-19 Drug Treatment / Hydroxychloroquine Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Diabetes Metab Res Rev Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article Affiliation country: Dmrr.3379